Abstract
Fatty acid synthase (FAS), a key enzyme of the fatty acid biosynthetic pathway, has been shown to be overexpressed in various types of human cancer and is, therefore, considered to be an attractive target for anticancer therapy. However, the exact mechanism of overexpression of the FAS gene in tumor cells is not well understood. In this report, we demonstrate that the expression of the tumor suppressor gene PTEN has a significant inverse correlation with FAS expression in the case of prostate cancer in the clinical setting, and inhibition of the PTEN gene leads to the overexpression of FAS in vitro. We also found that the combination of the expression status of these two genes is a better prognostic marker than either gene alone. Furthermore, our results indicate that the specific inhibition of FAS gene by siRNA leads to apoptosis of prostate tumor cells, and inhibition of PI 3-kinase pathway synergizes with FAS siRNA to enhance tumor cell death. These results provide a strong rationale for exploring the therapeutic use of an inhibitor of the PTEN signaling pathway in conjunction with the FAS siRNA to inhibit prostate tumor growth.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alo' PL, Visca P, Marci A, Mangoni A, Botti C and Di Tondo U . (1996). Cancer, 77, 474–482.
Cantley LC and Neel BG . (1999). Proc. Natl. Acad. Sci. USA, 96, 4240–4245.
Clegg DJ, Wortman MD, Benoit SC, McOsker CC and Seeley RJ . (2002). Diabetes, 51, 3196–3201.
Dahia PL . (2000). Endocrine Relat. Cancer, 7, 115–129.
De Schrijver E, Brusselmans K, Heyns W, Verhoeven G and Swinnen JV . (2003). Cancer Res., 63, 3799–3804.
Epstein JI, Carmichael M and Partin AW . (1995). Urology, 45, 81–86.
Gansler TS, Hardman III W, Hunt DA, Schaffel S and Hennigar RA . (1997). Hum. Pathol., 28, 686–692.
Heemers H, Maes B, Foufelle F, Heyns W, Verhoeven G and Swinnen JV . (2001). Mol. Endocrinol., 15, 1817–1828.
Innocenzi D, Alo PL, Balzani A, Sebastiani V, Silipo V, La Torre G, Ricciardi G, Bosman C and Calvieri S . (2003). J. Cutan. Pathol., 30, 23–28.
Jochen AL, Hays J and Mick G . (1995). Biochim. Biophys. Acta, 1259, 65–72.
Kridel SJ, Axelrod F, Rozenkrantz N and Smith JW . (2004). Cancer Res., 64, 2070–2075.
Kuhajda FP . (2000). Nutrition, 16, 202–208.
Kusakabe T, Nashimoto A, Honma K and Suzuki T . (2002). Histopathology, 40, 71–79.
Li JN, Gorospe M, Chrest FJ, Kumaravel TS, Evans MK, Han WF and Pizer ES . (2001). Cancer Res., 61, 1493–1499.
Magana MM and Osborne TF . (1996). J. Biol. Chem., 271, 32689–32694.
Malvoisin E and Wild F . (1990). Biochim. Biophys. Acta, 1042, 359–364.
Milgraum LZ, Witters LA, Pasternack GR and Kuhajda FP . (1997). Clin. Cancer Res., 3, 2115–2120.
Pflug BR, Pecher SM, Brink AW, Nelson JB and Foster BA . (2003). Prostate, 57, 245–254.
Piyathilake CJ, Frost AR, Manne U, Bell WC, Weiss H, Heimburger DC and Grizzle WE . (2000). Hum. Pathol., 31, 1068–1073.
Pizer ES, Pflug BR, Bova GS, Han WF, Udan MS and Nelson JB . (2001). Prostate, 47, 102–110.
Pizer ES, Wood FD, Heine HS, Romantsev FE, Pasternack GR and Kuhajda FP . (1996). Cancer Res., 56, 1189–1193.
Rashid A, Pizer ES, Moga M, Milgraum LZ, Zahurak M, Pasternack GR, Kuhajda FP and Hamilton SR . (1997). Am. J. Pathol., 150, 201–218.
Sebastiani V, Visca P, Botti C, Santeusanio G, Galati GM, Piccini V, Capezzone de Joannon B, Tondo U and Alo PL . (2004). Gynecol. Oncol., 92, 101–105.
Shurbaji MS, Kalbfleisch JH and Thurmond TS . (1996). Hum. Pathol., 27, 917–921.
Sul HS, Latasa MJ, Moon Y and Kim KH . (2000). J. Nutr., 130 (Suppl 2S), 315S–320S.
Suzuki H, Freije D, Nusskern DR, Okami K, Cairns P, Sidransky D, Isaacs WB and Bova GS . (1998). Cancer Res., 58, 204–209.
Swinnen JV, Heemers H, Deboel L, Foufelle F, Heyns W and Verhoeven G . (2000). Oncogene, 19, 5173–5181.
Swinnen JV, Roskams T, Joniau S, Van Poppel H, Oyen R, Baert L, Heyns W and Verhoeven G . (2002). Int. J. Cancer, 98, 19–22.
Takahashi KA, Smart JL, Liu H and Cone RD . (2004). Endocrinology, 145, 184–193.
Van de Sande T, De Schrijver E, Heyns W, Verhoeven G and Swinnen JV . (2002). Cancer Res., 62, 642–646.
Wang S, Gao J, Lei Q, Rozengurt N, Pritchard C, Jiao J, Thomas GV, Li G, Roy-Burman P, Nelson PS, Liu X and Wu H . (2003). Cancer Cell, 4, 209–221.
Woessmann W, Damm-Welk C, Fuchs U and Borkhardt A . (2003). Rev. Clin. Exp. Hematol., 7, 270–291.
Yang YA, Han WF, Morin PJ, Chrest FJ and Pizer ES . (2002). Exp. Cell. Res., 279, 80–90.
Acknowledgements
This work was supported by NIH (1R15V50079473, 5R01CA89438), DOD (PC031038), Illinois Department of Public Health and American Lung Association, Illinois, USA.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on Oncogene website (http://www.nature.com/onc)
Supplementary information
Rights and permissions
About this article
Cite this article
Bandyopadhyay, S., Pai, S., Watabe, M. et al. FAS expression inversely correlates with PTEN level in prostate cancer and a PI 3-kinase inhibitor synergizes with FAS siRNA to induce apoptosis. Oncogene 24, 5389–5395 (2005). https://doi.org/10.1038/sj.onc.1208555
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1208555
Keywords
This article is cited by
-
Reducing FASN expression sensitizes acute myeloid leukemia cells to differentiation therapy
Cell Death & Differentiation (2021)
-
Pancancer survival analysis of cancer hallmark genes
Scientific Reports (2021)
-
Fructose and prostate cancer: toward an integrated view of cancer cell metabolism
Prostate Cancer and Prostatic Diseases (2019)
-
Increased fatty acid synthase expression in prostate biopsy cores predicts higher Gleason score in radical prostatectomy specimen
BMC Clinical Pathology (2014)
-
Inhibitory effects of sea buckthorn procyanidins on fatty acid synthase and MDA-MB-231 cells
Tumor Biology (2014)